Niki BioSolutions NIKI
NASDAQ NIKI
$1.81 -0.13 (-6.70%)
As of: Oct 23, 2026 · 12:53 PM EDT

Niki BioSolutions (NIKI) Cash from Operations (2024 - 2025)

Updated

Niki BioSolutions (NIKI) recorded Cash from Operations of -$409,955 in FY2025.

Analysis

Niki BioSolutions (NIKI) Cash from Operations (2024 - 2025) Analysis & Trends

Starting with FY2017, Niki BioSolutions' Cash from Operations history includes 9 years.

  • The FY2025 figure is the highest annual Cash from Operations in data going back to FY2017.
  • Per Business Quant data, NIKI's Cash from Operations was -$1.19 million in FY2024, -$7.72 million in FY2023, -$12.32 million in FY2022 and -$14.65 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,132.26 Bn 1,100.85 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 634.57 Bn 554.43 Bn 17.30 Bn 7.72 Bn
3 AbbVie 505.88 Bn 478.99 Bn 12.70 Bn 3.44 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 291.59 Bn 255.58 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 265.00 Bn 238.69 Bn 12.86 Bn 2.87 Bn
7 Amgen 238.10 Bn 193.50 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 195.13 Bn 169.32 Bn 6.22 Bn 3.57 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 835.00 Mn
10 Niki BioSolutions 987,011.07 746,696.07 - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -171,585.00
Nov 30, 2024 -85,312.00
Aug 31, 2024 -60,549.00
API Access

Niki BioSolutions Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NIKI&period=max&api_key=YOUR_API_KEY